Showing results (551-560 of 634) with videos related to
Sort By:
Pageof 64
Journal of Biomedical Materials Research. Part A|August 11, 2007
Synthesis, characterization, and hydrolytic degradation behavior of a novel biodegradable pH-sensitive hydrogel based on polycaprolactone, methacrylic acid, and poly(ethylene glycol)Guo Tao Chao, Zhi Yong Qian, Mei Juan Huang, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2017
Intermedin Enlarges the Vascular Lumen by Inducing the Quiescent Endothelial Cell ProliferationLi-Jun Wang, Fei Xiao, Ling-Miao Kong, et al.Cell Death & Disease|June 22, 2019
Microglia-derived TNF-α mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic strokeAn-Qi Chen, Zhi Fang, Xiao-Lu Chen, et al.Arthritis Research & Therapy|February 28, 2018
MicroRNA-302b negatively regulates IL-1β production in response to MSU crystals by targeting IRAK4 and EphA2Teng Ma, Xiao Liu, Zhifu Cen, et al.Parasite (Paris, France)|November 24, 2020
Genotyping and zoonotic potential of Enterocytozoon bieneusi in cattle farmed in Hainan Province, the southernmost region of ChinaXin-Li Zheng, Huan-Huan Zhou, Gangxu Ren, et al.Military Medical Research|March 6, 2018
Expert consensus on the evaluation and diagnosis of combat injuries of the Chinese People's Liberation ArmyZhao-Wen Zong, Lian-Yang Zhang, Hao Qin, et al.Journal of Cellular Biochemistry|March 18, 2010
A novel zinc finger protein Zfp637 behaves as a repressive regulator in myogenic cellular differentiationKai Li, Jie Zhang, Jing-Jing Ren, et al.Anti-Cancer Drugs|April 23, 2005
Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabineYang Wu, Li Yang, Bing Hu, et al.International Journal of Cancer|February 17, 2009
Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor modelJing Wen, A-fu Fu, Li-Juan Chen, et al.International Journal of Radiation Oncology, Biology, Physics|April 6, 2018
Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation TherapyJie Lan, Rui Li, Li-Mei Yin, et al.Pageof 64